Abstract:Importance: Meningioma is the most common subsequent neoplasm following cranial irradiation among survivors of childhood cancer, but there are still uncertainties regarding the magnitude of the radiation dose-response association, potential modifiers of radiation risks, and the role of chemotherapy. Objective: To evaluate meningioma risk in survivors of childhood cancer following radiotherapy and chemotherapy and identify possible modifying factors of radiation-associated risk. Design, setting, and participants: This international case-control study pooled data from 4 nested case-control studies of survivors of childhood cancer diagnosed between 1942 and 2000, followed through 2016. Cases were defined as participants diagnosed with a subsequent meningioma. Controls were matched to cases based on sex, age at first cancer diagnosis, and duration of follow-up. Data were analyzed from July 2019 to June 2022. Exposures: Radiation dose (Gy) to the meningioma site and cumulative chemotherapy doses, including intrathecal and systemic methotrexate doses. Main outcomes and measures: The main outcome was subsequent meningioma, assessed using odds ratios (ORs) and excess odds ratios per gray (EOR/Gy). Results: The analysis included 273 survivors of childhood cancer who developed meningioma (cases) and 738 survivors who did not (controls), with a total of 1011 individuals (median [IQR] age at first cancer diagnosis 5.0 [3.0-9.2] years; 599 [59.2%] female). Median (IQR) time since first cancer was 21.5 (15.0-27.0) years. Increasing radiation dose was associated with increased risk of meningioma (EOR/Gy, 1.44; 95% CI, 0.62-3.61), and there was no evidence of departure from linearity (P = .90). Compared with survivors who were not exposed to radiation therapy, those who received doses of 24 Gy or more had more than 30-fold higher odds of meningioma (OR, 33.66; 95% CI, 14.10-80.31). The radiation dose-response association was significantly lower among patients treated at age 10 years or older compared with those treated before age 10 years (EOR/Gy, 0.57; 95% CI, 0.18-1.91 vs 2.20; 95% CI, 0.87-6.31; P for heterogeneity = .03). Risk associated with radiation remained significantly elevated 30 years after exposure (EOR/Gy, 3.76; 95% CI, 0.77-29.15). We found an increased risk of meningioma among children who had received methotrexate (OR, 3.43; 95% CI, 1.56-7.57), but no evidence of a dose-response association or interaction with radiation dose. Conclusions and relevance: These findings suggest that the meninges are highly radiosensitive, especially for children treated before age 10 years. These results support the reduction in whole-brain irradiation over recent decades and the prioritization of approaches that limit radiation exposure in healthy tissue for children. The persistence of elevated risks of meningiomas for 30 years after cranial radiotherapy could help inform surveillance guidelines.

Mathematical modeling of meningioma volume change after radiation treatment

Mathematical modeling of the treatment response of resection plus combined chemotherapy and different types of radiation therapy in a glioblastoma patient

Mathematical Modeling and Analysis of Tumor-Volume Variation During Radiotherapy

A kinetic model of tumor growth and its radiation response with an application to Gamma Knife stereotactic radiosurgery

Neurocognitive considerations in the treatment of meningioma with radiation therapy: applications for quantitative neuroimaging and precision radiation medicine

A semi-automatic segmentation method for meningioma developed using a variational approach model

A Population-Based Tumor-Volume Model for Head and Neck Cancer During Radiation Therapy With a Dynamic Oxygenated Compartment

Forecasting tumor and vasculature response dynamics to radiation therapy via image based mathematical modeling

Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy

Velocity and pattern of growth of intracranial meningiomas

Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model

Factors Influencing Long-Term Outcomes of Single-Session Gamma Knife Radiosurgery in Large-Volume Meningiomas >10 cc

Gamma Knife Radiosurgery for Intracranial Benign Meningiomas: Follow-Up Outcome in 130 Patients

Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer

Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma—Response

Gamma knife radiotherapy for radiation-induced meningioma: a case report and literature review

Guidelines to the treatment of meningioma

Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling

Radiotherapy in the Treatment of Meningiomas

Dose-staged Gamma Knife radiosurgery for meningiomas: A retrospective study in a single center

Post-operative gamma knife radiosurgery for WHO grade I intracranial meningiomas: A single-center, retrospective study